Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.

March 2, 2011 By Bio-Medicine.Org

SAN DIEGO, March 2, 2011 /PRNewswire/ — Accumetrics, Inc., a
privately-held developer and marketer of the VerifyNow System, the
first rapid and easy-to-use point-of-care diagnostic system for
measuring platelet reactivity to multiple antiplatelet agents,
announced today that the company has signed an agreement with
Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow
System and VerifyNowTests for use in clinical trials.

The VerifyNow System is widely used by practicing physicians to
assess patients’ platelet response to various antiplatelet
therapies already available on the market, such as aspirin, P2Y12
inhibitors (e.g. Plavix® and Effient®)and GP IIb/IIIa
inhibitors. The VerifyNow System is also a frequently used tool of
clinical researchers to measure the antiplatelet effect of drugs in
development.  By incorporating the VerifyNow System in
pharmaceutical clinical trials, data are generated to support the
integration of platelet reactivity testing in the patient care
pathway as new agents are introduced to the market.

“With the signing of this agreement, Accumetrics is solidifying
its role as a premier partner of pharmaceutical companies in the
development and validation of new and emerging antiplatelet drugs,”
said Timothy I. Still, President and CEO of Accumetrics.
 “With the trend towards individualized and targeted
approaches to treating patients, the VerifyNow System plays an
important role at both the commercial and development ends of the
spectrum.”

The VerifyNow System is widely used in various clinical settings
where antiplatelet medications are prescribed to reduce the
occurrence of future thrombotic events such as heart attack and
stroke.

About Accumetrics Accumetrics is committed to advancing
medical understanding of platelet function and enhancing quality of
care for patients receiving antiplatelet therapies by providing
industry-leading and widely accessible diagnostic tests for
ra

‘/>”/>

SOURCE

Related Articles Read More >

Prix Galien USA 2022 nominees
The 24 best medical device innovations of 2022
A portrait of Ellen Roche, MIT School of Engineering associate professor
New implant design prevents scar tissue without drugs, MIT says
UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’

DeviceTalks Weekly.

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech